Skip to content
10-Q

Quarterly Report

CARDIOVASCULAR SYSTEMS, INC.

0001180145-22-000052

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Oct 31, 2022 41.88M sh
Shares Diluted Q1 2023 · Sep 30, 2022 39.61M sh
Shares Diluted Q1 2023 · Sep 30, 2021 39.09M sh
Capex Q1 2023 · Sep 30, 2022 $688K
Capex Q1 2023 · Sep 30, 2021 $1.1M
Operating Cash Flow Q1 2023 · Sep 30, 2022 −$13.65M
Operating Cash Flow Q1 2023 · Sep 30, 2021 −$10.78M
Cash And Equivalents Q1 2023 · Sep 30, 2022 $62.85M
Cash And Equivalents Q1 2023 · Jun 30, 2022 $66.42M
Stockholders Equity Q1 2023 · Sep 30, 2022 $242.15M
Stockholders Equity Q1 2023 · Jun 30, 2022 $249.48M
Stockholders Equity Q1 2023 · Sep 30, 2021 $263.19M
Stockholders Equity Q1 2023 · Jun 30, 2021 $270.96M
Current Liabilities Q1 2023 · Sep 30, 2022 $37.16M
Current Liabilities Q1 2023 · Jun 30, 2022 $39.95M
Total Liabilities Q1 2023 · Sep 30, 2022 $69.89M
Total Liabilities Q1 2023 · Jun 30, 2022 $73.2M
Current Assets Q1 2023 · Sep 30, 2022 $231.08M
Current Assets Q1 2023 · Jun 30, 2022 $241.85M
Total Assets Q1 2023 · Sep 30, 2022 $312.04M
Total Assets Q1 2023 · Jun 30, 2022 $322.68M
Eps Diluted Q1 2023 · Sep 30, 2022 −$0.27
Eps Diluted Q1 2023 · Sep 30, 2021 −$0.22
Eps Basic Q1 2023 · Sep 30, 2022 −$0.27
Eps Basic Q1 2023 · Sep 30, 2021 −$0.22
Sga Expense Q1 2023 · Sep 30, 2022 $44.48M
Sga Expense Q1 2023 · Sep 30, 2021 $41.85M
Rd Expense Q1 2023 · Sep 30, 2022 $9.06M
Rd Expense Q1 2023 · Sep 30, 2021 $10.02M
Net Income Q1 2023 · Sep 30, 2022 −$10.63M
Net Income Q1 2023 · Sep 30, 2021 −$8.62M
Operating Income Q1 2023 · Sep 30, 2022 −$10.9M
Operating Income Q1 2023 · Sep 30, 2021 −$8.12M
Gross Profit Q1 2023 · Sep 30, 2022 $42.98M
Gross Profit Q1 2023 · Sep 30, 2021 $44.06M
Cost Of Revenue Q1 2023 · Sep 30, 2022 $16.7M
Cost Of Revenue Q1 2023 · Sep 30, 2021 $14.31M
Revenue Q1 2023 · Sep 30, 2022 $59.67M
Revenue Q1 2023 · Sep 30, 2021 $58.37M